10 Unrivaled Penny Stocks to Buy Now
For decades, penny stocks have occupied the wildest corner of Wall Street; a market where unknown companies can skyrocket into billion-dollar success stories overnight, but where countless investors also...
X4 Pharmaceuticals Inc (XFOR)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Winton Capital Management David Harding | 14,400 | $67,248 | +36% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.90 | 86,206 | $249,997.40 | 376,087 | 2025-10-23 | Filing | |
| $2.48 | 1,032 | $2,561.42 | 25,337 | 2025-05-16 | Filing | |
| $0.34 | 13,404 | $4,597.57 | 129,173 | 2024-11-15 | Filing | |
| $0.68 | 21,646 | $14,654.34 | 115,769 | 2024-05-17 | Filing | |
| $1.20 | 25,000 | $29,875.00 | 76,667 | 2023-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.26 | 8,543 | $36,428.21 | 167,750 | 2026-06-30 | Filing | |
| $4.29 | 16,961 | $72,820.36 | 176,293 | 2026-05-12 | Filing | |
| $0.45 | 76,473 | $34,718.74 | 1,087,386 | 2025-01-24 | Filing | |
| $0.45 | 74,773 | $33,946.94 | 0 | 2025-01-24 | Filing | |
| $0.45 | 29,159 | $13,241.10 | 94,123 | 2025-01-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,554,906 | $25,941,411 | 0% | |
| 2. | 1,296,017 | $6,052,399 | 0% | |
| 3. | 196,340 | $916,908 | 0% | |
| 4. | 95,726 | $447,040 | 0% | |
| 5. | 78,885 | $368,393 | 0% |
News See All
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the X4 Pharmaceuticals First Quarter 2025 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the X4 Pharmaceuticals Fourth Quarter and Full Year 2024 Financial and Operating Results Conference Call.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the X4 Pharmaceuticals Call and Webcast. At this time, all participants are in a listen-only mode.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.25884 EPS, expectations were $-0.17. X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.15.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to X4 Pharmaceuticals’ Third Quarter Financial and Operating Results Conference Call. At this time all participants are in a listen-only mode.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to X4 Pharmaceuticals' Second Quarter 2023 Financial and Operating Results Conference Call. [Operator Instructions] As a reminder, the conference call is being recorded.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to X4 Pharmaceuticals' First Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, the conference call is being recorded.
Hedge Fund Resource Center